UPC_APP_68655/2024

Procedural & sub-applicationsWithdrawal ApplicationsCourt of AppealApplication Rop 265—Settled at: Post-appeal

Parties

Claimants

Dexcom Inc.(Dexcom Group)

Reps: Anne-Charlotte le Bihan (Bird & Bird (Paris)); Laurent Labatte (Bird & Bird (Paris)); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)

Respondents

Abbott Laboratories(Abbott Group)
Abbott Diabetes Care Inc.(Abbott Group)
Abbott GmbH(Abbott Group)
Abbott Diagnostics GmbH(Abbott Group)
Abbott Logistics B.V.(Abbott Group)
Abbott (S.A./N.V.)(Abbott Group)
Abbott s.r.l.(Abbott Group)
Abbott B.V.(Abbott Group)
Abbott Scandinavia Aktiebolag(Abbott Group)
Abbott France (S.A.S.)(Abbott Group)

Judges

Patents

Outcome

Withdrawn

Filed: —

First decided: Jan 24, 2025

Language: —

Settled at: Post-appeal — settled commercially

The Court of Appeal allowed DexCom's withdrawal of its infringement action and Abbott's withdrawal of the counterclaims for revocation, declared the proceedings closed, and ordered reimbursement of 60% of DexCom's court fees; as a result the first instance decision revoking DexCom's patent became ineffective.